CGC vs VFF: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CGC and VFF share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CGC and VFF exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Canopy Growth Corporation is one of Canada's largest cannabis companies, based in Smiths Falls, Ontario. It sells recreational (adult-use) and medical cannabis in Canada, exports medical cannabis to international markets in Europe and Australia, and owns Storz & Bickel, a maker of premium vaporizer devices. Its revenue comes mainly from selling cannabis flower, pre-rolls, vapes, edibles, and beverages under brands like Tweed and Doja, plus device sales. In fiscal 2026 the company completed its acquisition of MTL Cannabis, a move it says makes it Canada's leading medical-cannabis provider by revenue, and reported that its core cannabis business returned to growth after years of contraction.

Full CGC guide

Village Farms International, Inc. spent decades as one of North America's largest vertically integrated greenhouse growers of fresh produce, supplying tomatoes, peppers, and cucumbers to grocery and large-format retailers across the US and Canada. It has redeployed that low-cost, high-yield greenhouse expertise into cannabis, and as of 2026 it has realigned into a single reportable segment: Cannabis. Its Canadian subsidiary Pure Sunfarms is one of the single largest cannabis operations in the world, running roughly 2.2 million square feet of greenhouse production plus additional idle capacity for future expansion, and it ranks among Canada's best-selling and highest-quality brands. Village Farms also owns 80% of Quebec-based Rose LifeScience, a cannabis commercialization and distribution company, and has been building an international export business into markets in Europe, Australia, and New Zealand.

Full VFF guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CGC drivers: Core cannabis business back to growth; MTL Cannabis and medical leadership.
• VFF drivers: Low-cost greenhouse advantage; Profitable, scaled Canadian cannabis.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The central risk is that Canopy is still unprofitable in a brutally competitive industry. For VFF, the largest risks are regulatory and structural.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CGC if you believe its drivers more; VFF if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CGC and VFF guides.

CGC. These figures are qualitative and tied to the asOf date; verify live numbers before acting. Because Canopy is unprofitable, standard earnings multiples do not apply, and the stock trades on revenue trajectory, cash runway, and expectations for cannabis reform rather than on profits. Reported financials are also in Canadian dollars, so US-dollar figures depend on exchange rates. Treat any single quarter with caution: cannabis results swing on pricing, one-time charges, and restructuring.

VFF. These figures are approximate, tied to the asOf date, and can change quickly given the company's small size and ongoing restructuring, so verify live numbers before acting. As a small-cap cannabis name in transition, its valuation is highly sensitive to policy news, financing, and sentiment across the sector, and reported profitability may not be durable. Treat any figures here as a starting point to check against current filings.

Headline figures (approximate, Jul 2026): CGC shows revenue trend (fy2026) Modest annual growth (roughly mid-single-digit percent), the first sustained return to growth after years of contraction, growth drivers Double-digit gains in Canadian adult-use, Canadian medical, and international cannabis; device sales (Storz & Bickel) were softer, profitability Still net-loss-making, but fiscal 2026 net loss from continuing operations narrowed roughly by half versus the prior year, balance sheet Shifted to a net-cash position after a January 2026 recapitalization, reducing near-term financing risk; VFF shows q1 2026 net sales ~$50 million, up roughly 27% year over year, q1 2026 profitability positive net income with sharply higher adjusted EBITDA, driven by record export sales, reporting structure realigned in 2026 into a single Cannabis segment, canadian capacity Pure Sunfarms runs ~2.2 million sq ft of greenhouse, with more idle capacity available.

CGC and VFF are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CGC and VFF exposure against your real portfolio. It is not an investment adviser.